Tower Research Capital LLC (Trc) Imv Inc. Transaction History

Tower Research Capital LLC (Trc)

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.56 - $1.45 $13,240 - $34,282	23,643 Added 1516.55%	25,202 $17,000
Q1 2022 May 12, 2022	BUY	$1.07 - $1.5 $1,668 - $2,338	1,559 New	1,559 $2,000
Q3 2021 Nov 15, 2021	SELL	$1.35 - $2.16 $3,146 - $5,034	-2,331 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.12 - $3.24 $4,941 - $7,552	2,331 New	2,331 $5,000
Q1 2021 May 17, 2021	SELL	$2.92 - $4.41 $8,234 - $12,436	-2,820 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.9 - $4.4 $8,178 - $12,408	2,820 New	2,820 $9,000

Ticker IMV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,452,200
Description
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is P...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.